92 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Conditions: Endometrial Clear Cell Carcinoma;   Ovarian Clear Cell Cystadenocarcinoma;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer
Interventions: Drug: dasatinib;   Other: laboratory biomarker analysis
22 Recruiting Follow-up of Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Other: Instruction in self-referral
23 Recruiting Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Condition: Endometrial Cancer
Interventions: Device: ISB dye and standard white light imaging;   Device: ICG dye and FireFly fluorescence imaging
24 Unknown  A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Drug: paclitaxel
25 Recruiting Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
Conditions: Endometrial Cancer;   Obesity
Interventions: Dietary Supplement: Dietary Intervention;   Other: Informational Material;   Other: Dietary Education;   Dietary Supplement: Weight Maintenance;   Other: Average score of Obesity and Weight-Loss Quality of Life Questionnaire
26 Not yet recruiting Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Condition: Endometrial Cancer
Intervention: Drug: Metformin
27 Recruiting Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Conditions: Complex Atypical Hyperplasia;   Endometrial Cancer
Intervention: Drug: Metformin
28 Recruiting Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: metformin hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Other: questionnaire administration
29 Recruiting Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Dasatinib
30 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy
31 Recruiting Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Device: MIrena(LNG-IUS), oral MPA
32 Unknown  Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
33 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
34 Recruiting Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: 3D conformational radiation;   Radiation: IMRT
35 Not yet recruiting Virexxa (Sodium Cridanimod) in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma
Condition: Recurrent or Persistent Endometrial Carcinoma
Intervention: Drug: Sodium cridanimod
36 Unknown  Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma
Condition: Endometrial Cancer
Intervention: Procedure: surgery
37 Recruiting Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Conditions: Cervical Cancer;   Uterine Endometrial Cancer;   Ovarian Cancer
Interventions: Procedure: Laparotomy;   Drug: intravenous narcotics;   Drug: standard anesthesia;   Drug: regional anesthesia;   Drug: Non-steroidal  anti-inflammatory drugs
38 Recruiting Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Selinexor
39 Recruiting Lymphedema After Primary Surgery for Endometrial Cancer
Conditions: Carcinoma of the Endometrium;   Hysterectomy;   Lymphadenectomy
Intervention: Procedure: Lymphadenectomy
40 Recruiting GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: BKM120

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years